In a landmark achievement to strengthen European security, CNS Solutions & Support, as a member of the Frequentis Group, has announced the completion of the CBRN Reconnaissance and Surveillance System (RSS).
In response to evolving threats, the Frequentis Group has developed an innovative data fusion cell (DFC) to integrate sensor and uncrewed systems data, through its incident crisis management (ICM) technology.
Innovative data fusion cell (DFC)
The DFC serves as a centralised hub, seamlessly integrating information from various sources including sensors and drones, therefore enabling comprehensive analysis and rapid decision-making.
"Our DFC has transformed CBRN defence in Europe, empowering military personnel with real-time intelligence to respond swiftly and effectively to emerging threats," Peter Skiczuk, Frequentis Vice President of Defence.
Mitigating risks
The adoption of state-of-the-art technologies, including drones equipped with sensors and uncrewed robotic vehicles
“CNS is dedicated to enhancing CBRN defence technologies. Future phases will focus on readiness for full military deployment, ensuring continued security for European nations," says Stefan Ringsmuth, Managing Director of CNS Solutions & Support GmbH.
The adoption of state-of-the-art technologies, including drones equipped with sensors and uncrewed robotic vehicles heralds a new era in CBRN defence. These uncrewed assets swiftly detect and assess hazardous substances, mitigating risks to human personnel.
Data fusion and real-time analysis
By leveraging data fusion and real-time analysis, commanders gain critical insights to make informed decisions, ensuring the safety of both military personnel and civilians.
"Normally, it would take us two hours to achieve this result. With the use of these modern technologies, we can reduce this time to 40 to 45 minutes, and we don’t have to bring soldiers directly to the source of danger, as this is taken over by robots and drones," says Colonel Schlechter, Commander of the CBRN Defence Center/Austria (ÖBH).